832735-48-5 Usage
Molecular structure
A cyclic amine (piperidine ring) with an ester group, a cyanophenyl group, and a pyridazinyl group attached to it.
Functional groups
Ester, amine, cyano, and pyridazinyl groups.
Esterification
The compound is an ester of 1-piperidinecarboxylic acid and 4-[[6-(4-cyanophenyl)-3-pyridazinyl]oxy].
Prodrug potential
The presence of the tert-butyl ester group suggests that 1-Piperidinecarboxylic acid, 4-[[6-(4-cyanophenyl)-3-pyridazinyl]oxy]-,
1,1-dimethylethyl ester may be used as a prodrug, which can be converted into its active form in the body.
Pharmaceutical applications
The cyanophenyl and pyridazinyl groups indicate that 1-Piperidinecarboxylic acid, 4-[[6-(4-cyanophenyl)-3-pyridazinyl]oxy]-,
1,1-dimethylethyl ester may have pharmaceutical applications, potentially as a drug for treating specific medical conditions.
Stability and pharmacokinetics
The 1,1-dimethylethyl ester group suggests that 1-Piperidinecarboxylic acid, 4-[[6-(4-cyanophenyl)-3-pyridazinyl]oxy]-,
1,1-dimethylethyl ester may have enhanced stability and improved pharmacokinetics, which are desirable properties for drug development.
Research and development potential
The chemical structure of 1-piperidinecarboxylic acid, 4-[[6-(4-cyanophenyl)-3-pyridazinyl]oxy]-, 1,1-dimethylethyl ester indicates that it has the potential to be a valuable compound for pharmaceutical research and development.
Check Digit Verification of cas no
The CAS Registry Mumber 832735-48-5 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,3,2,7,3 and 5 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 832735-48:
(8*8)+(7*3)+(6*2)+(5*7)+(4*3)+(3*5)+(2*4)+(1*8)=175
175 % 10 = 5
So 832735-48-5 is a valid CAS Registry Number.
832735-48-5Relevant academic research and scientific papers
HETEROARYLOXY NITROGENOUS SATURATED HETEROCYCLIC DERIVATIVE
-
Page/Page column 69, (2008/06/13)
Provided are compounds of a formula (I) and their pharmaceutically-acceptable salts: wherein X1, X2 and X3 each independently represent N or CH; W represents the following formula (II): or the following formula (III): Y represents a group of a formula (IV): The compounds have a histamine-H3 receptor antagonistic or inverse-agonistic activity and are useful for remedy and/or prevention of obesity, diabetes, hormone secretion disorders, sleep disorders, etc.
